@DewDiligence Agreed, but here's the issue: If you look at their legacy, they have managed to get a great deal each and every time with absolutely crappy data. $EYET Macugen: $PFE pre-IPO, then with $OSI after Lucentis was poised to kill Macugen -&gt; $OPHT Fovista: $NVS and $NVO -&gt; $ISEE ?